GlaxoSmithKline (GSK)

Sector:

Pharma and Biotech

Index:

FTSE 100

Trade now with BarclaysStockbrokers Trade now with Barclays Sponsored by Barclays Stockbrokers

1,498.60p
   
  • Change Today:
      16.80p
  • 52 Week High: 1,621.60
  • 52 Week Low: 1,242.80
  • Currency: UK Pounds
  • Shares Issued: 4,964.46m
  • Volume: 6,282,337
  • Market Cap: 74,397m
  • RiskGrade: 120
  • Beta: 0.01

GlaxoSmithKline Overview

UK-based GlaxoSmithKline is one of the world's leading pharmaceutical research companies. The company was created out of the merger between GlaxoWellcome and SmithKline Beecham in 2000.

1 Day Chart (18-01-2019)

1 Day Chart

6 Month Chart

6 Month Chart

Financials

Latest F'cast
Div Yield 5.3% 5.3%
Div Cover 1.4 1.4
Op Mrgn 13.5% 25.8%
ROCE n/a  
Latest F'cast
P/E 13.4 13.1
PEG 1.5 6.2
Pr/Revenue 2.5 2.4
Pr/Book 21.3  
Latest F'cast
Revenue 8.2% 1.3%
PBT 81.8% 124.0%
EPS 9.2% 2.1%
DPS n/a -0.1%

GlaxoSmithKline Fundamentals

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-13 26,505.00 6,647.00 108.40p 14.9 n/a -3% 78.00p 4.8%
31-Dec-14 23,006.00 2,968.00 95.40p 14.4 n/a -12% 80.00p 5.8%
31-Dec-15 23,923.00 10,526.00 75.70p 18.1 n/a -21% 80.00p 5.8%
31-Dec-16 27,889.00 1,939.00 102.40p 15.3 0.4 +35% 80.00p 5.1%
31-Dec-17 30,186.00 3,525.00 111.80p 11.8 1.3 +9% 80.00p 6.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

GlaxoSmithKline Forecasts

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-18 30,568.85 7,896.56 114.10p 13.1 6.4 +2% 79.94p 5.3%
31-Dec-19 31,655.22 7,645.16 112.39p 13.3 n/a -2% 80.06p 5.3%
31-Dec-20 33,567.64 8,288.34 118.08p 12.7 2.5 +5% 80.15p 5.3%

Copyright © 2019 FactSet Research Systems Inc. All rights reserved.

GlaxoSmithKline Company Announcements

Director/PDMR Shareholding 15-Jan-2019 17:15 RNS
Director/PDMR Shareholding 15-Jan-2019 16:09 RNS
Director/PDMR Shareholding 15-Jan-2019 15:01 RNS

Latest GlaxoSmithKline Director Deals

Traded Action Notifier PriceAmountValue
11-Jan-19 Buy Dividends David Redfern 1,536.00p 584 8,970.24
11-Jan-19 Buy Dividends Simon Dingemans 1,536.00p 1,457 22,379.52
11-Jan-19 Buy Dividends Emma Walmsley 1,536.00p 1,588 24,391.68

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

GlaxoSmithKline Market Data

Currency UK Pounds
Share Price 1,498.60p
Change Today 16.80p
% Change 1.13 %
52 Week High 1,621.60
52 Week Low 1,242.80
Volume 6,282,337
Shares Issued 4,964.46m
Market Cap 74,397m
Beta 0.01
RiskGrade 120

GlaxoSmithKline Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
76.2% below the market average76.2% below the market average76.2% below the market average76.2% below the market average76.2% below the market average
33.33% below the sector average33.33% below the sector average33.33% below the sector average33.33% below the sector average33.33% below the sector average
Price Trend
33.76% above the market average33.76% above the market average33.76% above the market average33.76% above the market average33.76% above the market average
52.54% above the sector average52.54% above the sector average52.54% above the sector average52.54% above the sector average52.54% above the sector average
Income
65.32% above the market average65.32% above the market average65.32% above the market average65.32% above the market average65.32% above the market average
83.33% above the sector average83.33% above the sector average83.33% above the sector average83.33% above the sector average83.33% above the sector average
Growth
33.46% above the market average33.46% above the market average33.46% above the market average33.46% above the market average33.46% above the market average
5.26% above the sector average5.26% above the sector average5.26% above the sector average5.26% above the sector average5.26% above the sector average

What The Brokers Say

Strong Buy 7
Buy 2
Neutral 14
Sell 0
Strong Sell 2
Total 25
neutral
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

GlaxoSmithKline Dividends

  Latest Previous
  Q3 Q2
Ex-Div 15-Nov-18 09-Aug-18
Paid 10-Jan-19 11-Oct-18
Amount 19.00p 19.00p

Trades for 18-Jan-2019

Time Volume / Share Price
17:10 2,185 @ 1,497.55p
17:10 19,711 @ 1,495.12p
16:35 1,477,066 @ 1,498.60p
16:30 59 @ 1,499.79p
16:30 744 @ 1,500.00p

GlaxoSmithKline Key Personnel

CFO Simon Dingemans
CEO Emma Walmsley

Top of Page